Stay updated on BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial
Sign up to get notified when there's something new on the BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial page.

Latest updates to the BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows revision v3.4.2 replacing v3.4.1. No study data or user-facing content appears to be changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page. No visible changes to the study details or layout.SummaryDifference0.0%

- Check33 days agoChange DetectedGlossary visibility controls were added (Show glossary / Hide glossary), and minor text updates adjust update-status labels and revision/version strings across the page.SummaryDifference0.4%

- Check40 days agoChange DetectedThe page now shows Revision: v3.3.4; there are no substantive changes to study details, contacts, locations, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded a consolidated 'Locations' section listing sites in AZ, FL, IN, OK, TX, Alberta, Newfoundland and Labrador, and Quebec, and removed the separate state/province location subsections. Updated the revision to v3.3.3 and removed the HHS Vulnerability Disclosure entry as well as the v3.3.2 note.SummaryDifference0.8%

- Check90 days agoChange DetectedAdded a note in Publications indicating that entries are automatically filled from PubMed and may not pertain to the study. Updated the Revision version from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial page.